A ketamine derivative, esketamine (under the brand name Spravato ®), is FDA-approved for treatment-resistant depression in adults.Although ketamine itself is not FDA-approved for any mental health disorder, dozens of clinics across the United States offer it off-label for depression, anxiety, and other conditions.

